Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penelope A Bradbury

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
Immunotherapy for lung cancerPenelope A Bradbury, Frances A Shepherd
Cancer Medicine|June 19, 2021
The effect of prior cancer on non-small cell lung cancer trial eligibilityMichael Herman, Zhihui Liu, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancerRaymond W Jang, Pierre K Isogai, Nicole Mittmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancerPeter M Ellis, Frances A Shepherd, Scott A Laurie, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
Analysis of serum protein levels of angiogenic factors and their soluble receptors as markers of response to cediranib in the NCIC CTG BR.24 clinical trialChristina L Addison, Keyue Ding, Lesley Seymour, et al.
The Oncologist|November 28, 2018
Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural MesotheliomaSara V Soldera, John Kavanagh, Melania Pintilie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21Christina L Addison, Keyue Ding, Huijun Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Uncommon EGFR mutations in advanced non-small cell lung cancerGrainne M O'Kane, Penelope A Bradbury, Ronald Feld, et al.
Clinical Lung Cancer|June 18, 2015
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24Jair Bar, Keyue Ding, Huijun Zhao, et al.
Hormones & Cancer|February 4, 2012
Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancerSri Navaratnam, Georgios Skliris, Gefei Qing, et al.
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
Immunotherapy for lung cancerPenelope A Bradbury, Frances A Shepherd
Cancer Medicine|June 19, 2021
The effect of prior cancer on non-small cell lung cancer trial eligibilityMichael Herman, Zhihui Liu, Frances A Shepherd, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 15, 2010
Derivation of utility values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 questionnaire values in lung cancerRaymond W Jang, Pierre K Isogai, Nicole Mittmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2014
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancerPeter M Ellis, Frances A Shepherd, Scott A Laurie, et al.
Lung Cancer (Amsterdam, Netherlands)|September 30, 2015
Analysis of serum protein levels of angiogenic factors and their soluble receptors as markers of response to cediranib in the NCIC CTG BR.24 clinical trialChristina L Addison, Keyue Ding, Lesley Seymour, et al.
The Oncologist|November 28, 2018
Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural MesotheliomaSara V Soldera, John Kavanagh, Melania Pintilie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 17, 2010
Plasma transforming growth factor alpha and amphiregulin protein levels in NCIC Clinical Trials Group BR.21Christina L Addison, Keyue Ding, Huijun Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|June 5, 2017
Uncommon EGFR mutations in advanced non-small cell lung cancerGrainne M O'Kane, Penelope A Bradbury, Ronald Feld, et al.
Clinical Lung Cancer|June 18, 2015
Angiotensin-Converting Enzyme and Aldosterone Serum Levels as Prognostic and Predictive Biomarkers for Cediranib in NCIC Clinical Trials Group Study BR.24Jair Bar, Keyue Ding, Huijun Zhao, et al.
Hormones & Cancer|February 4, 2012
Differential role of estrogen receptor beta in early versus metastatic non-small cell lung cancerSri Navaratnam, Georgios Skliris, Gefei Qing, et al.
Pageof 7